96227 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
CANNABINOID RECEPTOR MODULATORS
#302Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#303PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#304Processes for preparing oligomers
#305N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
#306Crystalline forms
#307S1PR2 antagonists and uses therefor
#308Cannabinoid receptor modulators
#309Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine
#310Benzimidazole derivatives
#311Acyclic Nucleoside Phosphonate Diesters
#312Pharmaceutical compounds for treatment of medical disorders
#313Triazole antimicrobial derivative, pharmaceutical composition and use thereof
#314Metalloenzyme inhibitor compounds
#315Prodrugs of Nh-acidic compounds
#316Kinase inhibitors
#317(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#318Antiviral agents
#319Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
#320Processes for preparing phosphorodiamidate morpholino oligomers
#321Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#322PRODRUGS OF NH-ACIDIC COMPOUNDS
#323Substituted quinazoline compounds and methods of use thereof
#324Processes for preparing phosphorodiamidate morpholino oligomers
#325Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
#326Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof
#327Heterocyclic compounds for the treatment of neurological and psychological disorders
#328Soluble C5aR antagonists
#329Phenylpyrrolidinone formyl peptide 2 receptor agonists
#330Substituted aminothiazoles
#331Protein proximity assay in formalin fixed paraffin embedded tissue using caged haptens
#332Hormone receptor modulators for treating metabolic conditions and disorders
#333Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#334Non-halogenated flame retardant hindered amine light stabilizer cross-linkers
#335Processes for the preparation of sofosbuvir and intermediates thereof
#336Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry
#337HETEROARYL COMPOUNDS FOR KINASE INHIBITION
#338Hepatitis B antiviral agents
#339Skeletal removal of bisphosphonates
#340Organic electroluminescence device and compound including nitrogen for organic electroluminescence device
#341Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#342TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS
#343Isatin-derived compounds, use of the compounds for the treatment of AIDS and method of treatment using these compounds
#344Antisense antibacterial compounds and methods
#345Bisphosphonate quinolone conjugates and uses thereof
#346S1PR2 antagonists and uses therefor
#347Sulfone pyridine alkyl amide-substituted heteroaryl compounds
#348Antiproliferative compounds, and their pharmaceutical compositions and uses
#349Benzazepine derivative, preparation method, pharmaceutical composition and use thereof
#350Acylphosphine oxide photoinitiators
#351Fosaprepitant phosphate intermediate and preparation method therefor
#352Amino compounds for treatment of complement mediated disorders
#353Compositions comprising a polymeric dye and a cyclodextrin and uses thereof
#354Heterocyclic compound and organic light-emitting device including the same
#355Quinone methide analog signal amplification
#356Quinone methide analog signal amplification
#357Charged linkers and their uses for conjugation
#358Charged linkers and their uses for conjugation
#359Charged linkers and their uses for conjugation
#360S1PR2 ANTAGONISTS AND USES THEREFOR
#361Hydrophilic linkers and ligand-drug conjugates thereof
#362(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZYL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
#363Ultraviolet light stabilizing polymeric filler materials
#364Aminothiazole derivatives useful as antiviral agents
#365Oligonucleotides for treating expanded repeat diseases
#366Phosphonate compounds for treatment of complement mediated disorders
#367Heterocyclic compounds for the treatment of neurological and psychological disorders
#368PH responsive fluorescent compound, composition for detecting mitophagy using same, and method for detecting mitophagy within cells
#369Ether compounds for treatment of complement mediated disorders
#370Electrochromic compound, electrochromic composition, and display element
#371Compounds for treatment of complement mediated disorders
#372Prodrugs of NH-acidic compounds
#373Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
#374Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#375Phosphine-based compound and organic electroluminescence device including the same
#376Metalloenzyme inhibitor compounds
#377Soluble C5aR antagonists
#378COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#379N-HYDROXYFORMAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THEM FOR USE AS BMP l, TLL1 AND/OR TLL2 INHIBITORS
#380Acyclic nucleoside phosphonate diesters
#381Process for preparation of fosaprepitant dimeglumine and an intermediate thereof
#382CANNABINOID RECEPTOR MODULATORS
#383Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
#384NOVEL OXAZOLIDINONE DERIVATIVES
#385BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#386Preparation method for tedizolid, tedizolid intermediate, and preparation method therefor
#387Kinase inhibitors
#388Bortezomib conjugates and methods using same
#389Method for preparing oxazolidinone intermediate
#390In Situ Chemiluminescent Substrates and Assays
#391Alkyne Compounds for Treatment of Complement Mediated Disorders
#392Crystalline Forms of Fosnetupitant
#393ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#394ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#395CANNABINOID RECEPTOR MODULATORS
#396Phospholipidation of imidazoquinolines and oxoadenines
#397Compositions and methods for inhibition of the JAK pathway
#398Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
#399Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
#400Functionally-modified oligonucleotides and subunits thereof
#401Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers
#402STAT6 inhibitors
#403Metalloenzyme inhibitor compounds
#404Chelated PSMA inhibitors
#405SUBSTITUTED OXOTETRAHYDROQUINOLINYLPHOSPHINIC ACID AND PHOSPHINIC ACID AMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS
#406Protein proximity assay in formalin fixed paffafin embedded tissue using caged haptens
#407Amide compounds for treatment of immune and inflammatory disorders
#408Antiproliferative compounds, and their pharmaceutical compositions and uses
#409Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
#410Ultra bright dimeric or polymeric dyes with spacing linker groups
#411Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
#412Compositions and methods for inhibition of the JAK pathway
#413Heterocyclic compounds for the treatment of neurological and psychological disorders
#414Bisphosphonates vinylic monomers and polymers and uses thereof
#415Hydrophilic linkers and ligand-drug conjugates thereof
#416Heterocyclic amides useful as protein modulators
#417Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
#418Compositions and methods of targeting mutant K-RAS
#419Indazolones as modulators of tnf signaling
#420ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#421Acyclic nucleoside phosphonate diesters
#422FLUORESCENT BISPHOSPHONATE ANALOGS
#423Acyclic nucleoside phosphonate diesters
#424Electrochromic compound, electrochromic composition, electrochromic element, and electrochromic dimming element
#425Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine
#426Crystalline fosaprepitant dicyclohexylamine salt and its preparation
#427Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#428Compounds for treatment of complement mediated disorders
#429Ether compounds for treatment of complement mediated disorders
#430Heterocyclic compound and organic light-emitting device including the same
#431Solid supports and phosphoramidite building blocks for oligonucleotide conjugates
#432Heterocyclic compounds and use thereof
#433TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES
#434Electrochromic material and transmittance variable panel and display device including the same
#435Condensed cyclic compound and an organic light-emitting device including the same
#436NOVEL OXAZOLIDINONE DERIVATIVES
#437Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same
#438Conjugated bisphosphonates for the diagnosis and therapy of bone diseases
#439Annelated phenoxyacetamides
#440Acyclic nucleoside phosphonate diesters
#441Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#442Amide compounds for treatment of complement mediated disorders
#443SOLUBLE C5aR ANTAGONISTS
#444Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
#445Process for synthesizing oxidized lactam compounds
#446Phosphonate compounds for treatment of complement mediated disorders
#447ANTIBACTERIAL COMPOUNDS
#448NO- and HS-releasing compounds
#449Heteroaryl compounds for kinase inhibition
#450Kinase inhibitors
#451Antibacterial antisense oligonucleotide and method
#452Thienopyrimidine and thienopyridine compounds and methods of use thereof
#453Aminopyrimidine kinase inhibitors
#454Factor D Inhibitors Useful for Treating Inflammatory Disorders
#455Tropomyosin-related kinase (Trk) inhibitors
#456Phosphonate nucleosides useful in the treatment of viral diseases
#457PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#458Thiol-containing cleave reagents and oxidative wash
#459Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#460Heteroaryl compounds for kinase inhibition
#461Amino compounds for treatment of complement mediated disorders
#462Condensed cyclic compound and organic light-emitting device including the same
#463Tank-binding kinase inhibitor compounds
#464Organic light emitting device and display device having the same
#465Substituted pyrimidines for inhibiting Raf kinase activity
#466Compositions and methods for inhibition of the JAK pathway
#467Charged linkers and their uses for conjugation
#468Compound and organic light-emitting device including the same
#469Cannabinoid receptor modulators
#470Compositions and methods for inhibition of the JAK pathway
#471Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide
#472Compounds and compositions as kinase inhibitors
#473Benzimidazole derivatives
#474KLK4 inhibitors
#475Activators of glucokinase
#476Quinone methide analog signal amplification
#477Chelated PSMA inhibitors
#478Ether compounds for treatment of medical disorders
#479Phosphonate compounds for treatment of medical disorders
#480Compositions useful for treating disorders related to kit
#481Polymerizable resins containing a 1,3,5-hexahydro-1,3,5-triazine moiety, methods of making, and dental compositions containing the same
#482NOVEL ANNELATED PHENOXYACETAMIDES
#483Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof
#484Kinase inhibitor
#485Pyrimidine derivatives
#486Prodrugs of NH-acidic compounds
#487Hepatitis B antiviral agents
#488Crystalline form of oxazolidinone antibiotics and preparation method, composition and use thereof
#489Acyclic nucleoside phosphonate diesters
#490Functionally-modified oligonucleotides and subunits thereof
#491Phosphorous Derivatives as Kinase Inhibitors
#492ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#493PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#494Amide compounds for treatment of complement mediated disorders
#495SELECTIVE SOLVENT FREE PHOSPHORYLATION
#496Crystalline fosaprepitant dicyclohexylamine salt and its preparation
#497Kinase inhibitors
#498Compounds and uses thereof for the modulation of hemoglobin
#499Urea derivatives useful as kinase inhibitors
#500Heterocyclic compounds for the treatment of neurological and psychological disorders
#501INDAZOLONES AS MODULATORS OF TNF SIGNALING
#502Substituted quinazoline compounds and methods of use thereof
#503Hepatitis B antiviral agents
#504Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
#505Phosphine ligands for catalytic reactions
#506Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease
#507Organic compound, electrochromic element containing the same, optical filter, lens unit, imaging device, and window component
#508Compounds for inhibiting cell proliferation in EGFR-driven cancers
#509Therapeutically active compositions and their methods of use
#510Voriconazole sodium phosphate hydrates and polymorphs thereof
#511Metalloenzyme inhibitor compounds
#512Adsorption of immunopotentiators to insoluble metal salts
#513Cytotoxic agents for conjugation to a cell binding molecule
#514Chemical Compounds
#515Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
#516Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
#517STAT6 inhibitors
#518Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#519Semiconducting material comprising aza-substituted phosphine oxide matrix and metal salt
#520Electrochromic compound, electrochromic composition, display element, and dimming element
#521Kinase inhibitors
#522Kinase inhibitor
#523Bone targeted therapeutics and methods of making and using the same
#524Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor
#525Heterocyclic compounds and use thereof
#526ERK inhibitors and uses thereof
#527Compounds and compositions as kinase inhibitors
#528Fused pyrimidine compounds and use thereof
#529Phosphonate compounds
#530Targeted delivery of anti-fungal agents
#531Organic electroluminescent element, and lighting device and display device which are provided with same
#532Prodrugs of bicyclic substituted pyrimidine type PDE-5 inhibitors
#533Factor XIa inhibitors
#534THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#535COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#536Process for synthesizing oxidized lactam compounds
#537Modified nucleic acid
#538Acyclic nucleoside phosphonate diesters
#539Substituted 2-aminopyridine protein kinase inhibitor
#540ERK inhibitors and uses thereof
#541Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#542Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
#543Water-soluble complexing agents and corresponding lanthanide complexes
#544Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
#545MITOCHONDRIA-TARGETED THERANOSTIC AGENTS
#546OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS
#547Glucokinase activator compounds, compositions containing such compounds, and methods of treatment
#5482-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
#549Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents
#550TARGETED MORPHOLINO LIGANDS AND USES THEREOF
#551Antibacterial compounds
#552Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
#553Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide
#554Compositions and methods for inhibition of the JAK pathway
#555Methods for preparing anti-viral nucleotide analogs
#556Linkers for conjugation of cell-binding molecules
#557Electrochromic compound, electrochromic composition, and display element
#558Tropomyosin-related kinase (TRK) inhibitors
#559Compositions and methods for inhibition of the JAK pathway
#560Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
#561Condensed cyclic compound and organic light-emitting device including the same
#562Water-soluble O-carbonyl phosphoramidate prodrugs for therapeutic administration
#563Phosphonate compounds for treatment of complement mediated disorders
#564Ether compounds for treatment of complement mediated disorders
#565Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#566Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#567Amino compounds for treatment of complement mediated disorders
#568Amide compounds for treatment of complement mediated disorders
#569Alkyne compounds for treatment of complement mediated disorders
#570Compounds for treatment of complement mediated disorders
#571Factor D inhibitors useful for treating inflammatory disorders
#572PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS
#573Herbicidally and fungicidally active 3-heteroaryl-isoxazoline-5-carboxamides and 3-heteroaryl-isoxazoline-5-thioamides
#574Anti-Viral Compounds
#575Aminopyrimidine kinase inhibitors
#576Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
#577Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl] pyridine-3-sulfonamide
#578Bisphosphonates vinylic monomers and polymers and uses thereof
#5791-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
#580Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
#581Macrocyclic factor VIIa inhibitors
#582Ring-substituted N-pyridinyl amides as kinase inhibitors
#583Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#584Activators of glucokinase
#585Phosphine derivatives of fluorescent compounds
#586Substituted pyrazole-containing compounds and their use as pesticides
#587Boronic acid conjugates of oligonucleotide analogues
#588Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
#589Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease
#590COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#591Phosphonate compounds
#592Fluorescent phospholipid ether compounds, compositions, and methods of use
#593Targeting delivery of anti-fungal agents
#594Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
#595Tetra- and pentasubstituted benzimidazolium compounds
#596Benzimidazolium compounds
#597Acyclic nucleoside phosphonate diesters
#598Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#599NOVEL OXAZOLIDINONE DERIVATIVES
#600Substituted pyrimidines